scispace - formally typeset
A

Ana Catarina Silva

Researcher at University of Porto

Publications -  74
Citations -  2052

Ana Catarina Silva is an academic researcher from University of Porto. The author has contributed to research in topics: Solid lipid nanoparticle & Drug delivery. The author has an hindex of 19, co-authored 63 publications receiving 1389 citations. Previous affiliations of Ana Catarina Silva include Fernando Pessoa University.

Papers
More filters
Journal ArticleDOI

Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review

A. Garcês, +3 more
- 15 Jan 2018 - 
TL;DR: Despite the cutaneous use of SLN and NLC has been proposed for both local and transdermal delivery, the reported studies show promising results only for local application, so more research is required to better understanding the interaction mechanisms of lipid nanoparticles with skin lipids.
Journal ArticleDOI

Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound

Ana Catarina Silva, +9 more
- 01 Aug 2011 - 
TL;DR: It is concluded that SLN can be considered as efficient carriers for RISP encapsulation and HPH and US revealed to be both effective methods for SLN production.
Journal ArticleDOI

Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity.

Alves Mendes, +5 more
- 01 Nov 2013 - 
TL;DR: It was demonstrated that the encapsulation of miconazole in NLC allows for obtaining the same therapeutic effect of a commercial oral gel formulation, using a 17-fold lower dose of miconsazole.
Journal ArticleDOI

Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.

Ana Catarina Silva, +5 more
- 15 Oct 2012 - 
TL;DR: The RISP-loaded SLN systems were stable and had high EE and similar shape to the placebo formulations before and after storage, and the viability of SLN as formulations for oral delivery of poorly water-soluble drugs such as RISP was illustrated.
Journal ArticleDOI

Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis.

Cláudia Pina Costa, +5 more
- 10 Feb 2019 - 
TL;DR: This review highlights the potential of using lipid-based nanosystems in the management of epilepsy and anxiety, by means of the nasal/intranasal route, and indicates the need for more in vivo experiments to further advance.